"

Understanding Schizophrenia:

A GUIDE FOR PEOPLE WITH

SCHIZOPHRENIA

AND THEIR

FAMILIES

 

Source: NARSAD RESEARCH

 

WHAT IS SCHIZOPHRENIA?

Schizophrenia is a serious brain disorder. It is a disease that makes it difficult for a person to tell the difference between real and unreal experiences, to think logically, to have normal emotional responses to others, and to behave normally in social situations. People with schizophrenia may also have difficulty in remembering, talking, and behaving appropriately.

            Schizophrenia can be very draining on both the people with schizophrenia and their families. People with schizophrenia often have difficulty functioning in society; they cannot work or go to school. Family members often have to help out financially and make sure that medicine is taken.

            Schizophrenia is not a “split personality.” It also is not caused by bad upbringing, personal weakness, or laziness. Schizophrenia is a disease with a physical cause, like cancer or heart disease.

            In addition, schizophrenia is a very costly illness. In the United States, it costs as much as $48 billion each year. This total includes the costs of medical treatment, Social Security payments, and wages lost because of illness for every person with the disease.

            There is no cure for schizophrenia today, but proper treatment can usually control the symptoms. With treatment, most people with schizophrenia can lead productive and fulfilling lives- working, living with their families, and enjoying friendships.

 

 

WHO GETS SCHIZOPHRENIA?

Schizophrenia is one of the most common mental illnesses. About 1% of the world population has schizophrenia. In the United States, there are about 2.5 million people with this disease. Schizophrenia is the cause of more hospitalizations than almost any other illness.

            Schizophrenia most commonly begins between the ages of 15 and 25. Although it strikes men and women equally, the symptoms may appear later in women than in men. Very rarely, the symptoms of schizophrenia can appear before the age of 12. Such childhood schizophrenia has a more chronic disease course and involves poor early language development.

 

WHAT ARE THE SYMPTONMS OF SCHIZOPHRENIA?         

People with schizophrenia can have a variety of symptoms. Sometimes, these symptoms come on suddenly. Usually, though, the illness develops slowly over months, even years. At first, the symptoms may not be noticed or may be confused with those of other conditions. For example, people with schizophrenia may feel tense, be unable to concentrate, or have trouble sleeping. They often become increasingly isolated and withdrawn as their grip with reality loosens. They do not make or keep friends. They may stop caring about the way they look. Dropping out of school or doing badly at work are other early signs of schizophrenia.

            As the illness progresses, symptoms of psychosis develop. The person starts to act strangely and talk nonsensically. People with schizophrenia may develop hallucinations; that is, they may see, feel, smell or hear things that are not really there. They may have physical symptoms, like frowning or unusual movements, and may stand or sit in strange positions. Some people become almost motionless. Others move around constantly.

            The severity of symptoms varies from one person to another. The symptoms also tend to worsen and improve. When the symptoms are improved, the person may appear to behave relatively normally, but usually there will be repeated episodes of the illness (relapses) that will cause symptoms to reappear.

            The symptoms of schizophrenia usually fall into two large categories: positive and negative symptoms. Positive symptoms include paranoia, auditory hallucinations, and bizarre behavior. Negative symptoms

include the lack of initiative and inability to relate to others that often results in persons with schizophrenia withdrawing from society. Some symptoms of schizophrenia, together with their medical names, are shown in the box.

 

 

Common Symptoms of Schizophrenia

POSITIVE (abnormal thoughts and perceptions)

 

·         Disordered thinking: Thoughts “jump” between completely unrelated topics or may be “blocked.”

                     The person may talk nonsense, make up words, or replace words with sounds and rhymes..

·Delusions: False beliefs or thoughts, make up words, or replace words with sounds and rhymes with no basis s

·                              inin reality. Example: Someone from the house next door is trying to control the patient’s thoughts or feelings.

·         Hallucinations: Hearing, seeing, or feeling things that are not there. People with schizophrenia may hear voices that may comment on their behavior or give them commands.

 

NEGATIVE (loss or decrease of normal functions)

 

·         Blunted (or flat) affect: Lacking awareness of other people’s feelings. The person does not show feelings or emotions on the face. The face looks “blank” compared with the face of someone without  schizophrenia. The person avoids eye contact and makes few gestures or movements. The person does not respond with normal conversation when spoken to. In severe cases, the person may become nearly motionless (catatonia).

 

·         Avolition: Lacking energy, spontaneity, initiative.

 

·         Anhedonia: Lacking pleasure or interest in activities that were once enjoyable.

 

·         Attention deficit: Difficulty in concentrating.

 

  

HOW IS SCHIZOPHRENIA DIAGNOSED?

Because other diseases can also cause symptoms of psychosis, psychiatrists ( medical doctors who specialize in the treatment of mental illnesses) should make the final diagnosis. The diagnosis is made based on a thorough psychiatric interview of the person and family members. As yet, there are no medical tests for schizophrenia.

            There are also disorders that may be related to schizophrenia. These include schizotypal personality disorder, which is a milder form of schizophrenia, and schizoaffective disorder, in which schizophrenia is accompanied by inappropriate “highs” (mania) or depression.

 

DEPRESSION, SUICIDE, AND SCHIZOPHRENIA

Depression is a real danger in people with schizophrenia. A person with schizophrenia is especially likely to have attacks of severe depression in the time between psychotic episodes.

            About two of every ten people with schizophrenia try to commit suicide, and about half of them succeed... In fact, suicide is the number one cause of death for young people with schizophrenia.

            The reason? In rare cases, people act under the influence of delusions or hallucinations, such as hearing voices. But suicide is usually the result of depression that occurs when people with schizophrenia are thinking relatively clearly and have some understanding of their illness.

 

WHAT CAUSES SCHIZOPHRENIA?

Schizophrenia is a complex and puzzling illness. Even the experts are not sure exactly what causes it. Some doctors think that the brain may not be able to process information correctly. In the next section, we will discuss some of the structural and chemical abnormalities that cause the brains of people with schizophrenia to get overloaded by too much information from the outside world. People without schizophrenia usually filter our unneeded information: for example, the sound of a dog barking next door. People with schizophrenia, however, cannot always filter out this extra information.

 

Heredity

One possible cause of schizophrenia may be heredity, or genetics. Experts think that some people inherit a tendency to schizophrenia. In fact, the disorder tends to “run” in families, but only among blood relatives.

            People who have family members with schizophrenia may be more likely to get the disease themselves. If both biologic parents have schizophrenia, there is nearly a 40% chance that their child will get it, too. This happens even if the child is adopted and raised by mentally healthy adults. In people who have an identical twin with schizophrenia, the chance of schizophrenia developing is almost 50%.

            In contrast, children whose biological parents are mentally healthy-even if their adoptive parents have schizophrenia-have about a 1% chance of getting the disease. That is about the same risk as for the general population shown in the chart.

 

Chances of Schizophrenia Developing

General population                            1%

Brother or sister has schizophrenia    8%

One parent has schizophrenia            12%

Fraternal twin has schizophrenia       14%

Both parents have schizophrenia       39%

Identical twin has schizophrenia       47%

 

                Schizophrenia is not passed on directly, like eye or hair color. Other conditions are necessary because other factors are involved. Otherwise, schizophrenia would always develop in both identical twins, since they have the same heredity.

 

 

Environment

Some researchers believe that events in a person’s environment trigger schizophrenia. Some studies have shown that influenza infection or improper nutrition during pregnancy and complications during birth may increase the risk that the baby will develop schizophrenia latter in life.

            Many researchers believe schizophrenia is likely caused by a complex combination of genetic and environmental factors. Certain people are born with a tendency to develop the disease. But the disease only appears if these people are exposed to unusual stresses or traumas.

 

WHAT HAPPENS IN THE BRAIN IN SCHIZOPHRENIA?

People with schizophrenia may have a chemical imbalance in the brain. They may be either very sensitive to or produce too much of a substance called dopamine. Dopamine is one of several brain chemicals (neurotransmitters) that allow nerve cells to send messages to each other. Researchers have found several types of dopamine receptors in different parts of the brain. Other neurotransmitters and their receptors also may be affected in people with schizophrenia.

            Researchers have used modern techniques to show the differences between the brains of people with schizophrenia and those of mentally healthy people. Specialized tests that produce images (scans) of the inside of the brain show differences in the size and shape of certain brain structures in people with schizophrenia compared with those of mentally healthy people. For example, in people with schizophrenia, there is enlargement of the fluid-filled cavities of the brain called ventricles. Similarly, there is a decrease in the size of the part called the hippopcampus. Other tests have shown that in the brains of people with schizophrenia there is less activity in the prefrontal cortex, the part of the brain that governs thought and higher mental functions.

 

HOW IS SCHIZOPHRENIA TREATED?

Schizophrenia is usually treated with antipsychotic medication. Some people with schizophrenia also benefit from counseling and rehabilitation. They may need to go to the hospital during an acute attack. The goal of treatment is to reduce symptoms during acute attacks and to help prevent relapses. At this time, there is no cure for schizophrenia.

 

Antipsychotic Medications

Antipsychotic medications (often called neuroleptics) are very effective in controlling the symptoms of schizophrenia. These medications first became available in the mid-1950s. They have greatly improved the lives of thousands of people. Before that time, people with schizophrenia spent most of their lives in crowded hospitals. With antipsychotic medication, however, many people with schizophrenia are able to live in the outside world.

            Because each person with schizophrenia has a unique mix of symptoms, no single medication works best for all people. The ideal medication for one person may not be the best choice for another. Although antipsychotic medications do not cure the disease, they can reduce hallucinations and delusions and help people with schizophrenia regain their grip on reality. Medication also reduces the risk of the symptoms returning. If the person does have a relapse of symptoms, medications may make the symptoms less severe.

            Unfortunately, many people with schizophrenia do not take the medications they need. Understanding the importance of medication to control schizophrenia is important for patients, family members, and the community.

 

Counseling and Rehabilitation

People with schizophrenia can have a hard time communicating with other people and carrying out ordinary tasks. This is true even when the positive symptoms are reduced. Counseling and rehabilitation can help people with schizophrenia build the skills they need to function outside the sheltered setting of a hospital. However, these treatments are not very helpful during acute attacks.

            Rehabilitation programs may help people with schizophrenia develop skills needed for ordinary life (money management, cooking, and personal grooming, for example). They may also prepare the person to go or return to work. Individual psychotherapy (sometimes called talk therapy) may help persons with schizophrenia learn to sort out the real fromorm the unreal. Group therapy may help them learn to get along with others. Self-help groups may help persons with schizophrenia (and family members) feel that others share their problems.

            Family therapy can also be very helpful. Family members often help care for people with schizophrenia. It is important that caregivers understand the disease and its treatment. Families and other people in the community need to provide support for persons with schizophrenia coming out of the hospital. Family members are also taught to watch for signs of relapse. This helps them make sure that the person gets medical help and takes the medications that prevent symptoms from returning.

 

WHAT DO ANTIPSYCHOTIC MEDICATIONS DO?

Antipsychotic medications work by changing the balance of chemicals in the brain. There are two major types of antipsychotics: traditional antipsychotics and newer antipsychotics.

 

Traditional Antipsychotics

The traditional antipsychotic medications control the positive symptoms (hallucinations, delusions, confusion) of schizophrenia very effectively. Researchers believe that part of this effect may be explained by the way these medications affect the brain chemical dopamine. This group of medications seems to block dopamine type 2 receptors from taking up the information carried by dopamine. Dopamine regulates many normal body functions, including movement, emotions, behavior, and appetite. Many of these functions are affected in people with schizophrenia. Some researchers think that the positive symptoms of schizophrenia-delusions, hallucinations, and confusion-may be caused by too much dopamine in the brain (or very sensitive dopamine receptors).

            Even though typical antipsychotics do much good, many persons with schizophrenia stop taking them. They stop for two reasons.

            First, these medications may have unpleasant side effects, especially at higher doses. Some side effects, such as dry mouth, blurred vision, constipation, and dizziness (which are called anticholinergic effects), and drowsiness are not serious. These side effects usually disappear a few weeks after the person starts treatment. More serious side effects cause trouble with muscle control. Because they also block receptors in the part of the brain that controls muscle movement, these medications may cause movement disorders, or extrapyramidal side effects (EPS). More than 60% of people who take traditional antipsychotics experience some form of EPS. They may have muscle spasms or cramps in the head and neck (dystonia), or they may fidget or pace restlessly (akathisia). Some may develop symptoms like those affecting people with Parkinson’s disease. These effects include tremors and shuffling of the feet. About one third of people who take traditional antipsychotics will develop facial tics, thrusting and rolling of the tongue, lip licking, panting, and grimacing (tardive dyskinesia).

            Second, these medications do not improve the negative symptoms of schizophrenia (such as depression and emotional withdrawal). This is probably because brain chemicals other than dopamine control the negative symptoms.

 

Newer Antipsychotics

The newer antipsychotics are also effective in treating the positive symptoms of schizophrenia. This group of medications may also be effective against the negative symptoms.

            These newer antipsychotics do not seem to cause as many problems with muscle control. This may be because, in addition to dopamine, they block another neurochemical, called serotonin. Also, they are selective: they work only on the part of the brain that causes the psychotic symptoms but not on the part that controls normal muscle movement.

            One newer antipsychotic is clozapine (Sandoz Pharmaceiutical Corp.). It is more selective for serotonin receptors and dopamine subtype receptors other than dopamine type 2 receptors. Clozapine is very effective in treating psychotic symptoms without causing EPS. However, because it blocks many receptors, in the brain other than just dopamine and serotonin receptors, clozapine tends to cause sedation and the anticholinergic effects of the traditional antipsychotics-dry mouth, blurred vision, constipation, and dizziness. In a small number of people, clozapine also causes a large weight gain, seizures, and considerable drooling. Clozapine has also been known to cause a significant reduction ion the number of infection-fighting white cells in the blood. Because of this, people taking this medication must have blood test taken once a week.

            Another newer antiphotic is risperidone (Janssen Pharmaceeutical  Inc.). It is believed to block both dopamine type 2 and serotonin type 2 receptors and relieves both the positive and negative symptoms of schizophrenia. Risperidone has a reduced risk of EPS, anticholinergic effects, and sedation. It is safer than colzapine but tends to cause EPS at higher doses.

            Approved by the FDA in late 1996, olanzapine (Eli Lilly and Co.) is similar to clozapine. It is effective against both positive and negative symptoms and causes very little EPS. Because, like clozapine, olanzapine blocks many more receptors in the brain than just dopamine and serotonin receptors, , olanzapineclospine can cause some sedation and anticholinergic effects.   

 

 Newest Generation of Antipsychotics

It is hoped that the development of the newest generation of antipsychotics will prove to be a great help to people with schizophrenia, providing better control of symptoms with fewer side effects. Quetiapine and sertindole are awaiting FDA approval in mid-1997. Ziprasidone filed for FDA approval in March of 1997.

            Quetiapine (Zeneca Pharmaceuticals) blocks a variety of receptors but is more selective for serotonin type 2 receptors than dopamine type 2 receptors. It is also more selective for receptors in the part of the brain responsible for psychotic symptoms and has minimal effect on muscle tone. Quetiapine is also effective against both positive and negative symptoms. Quetiapine showed no difference in EPS and prolactin levels compared to placebo in controlled clinical trials across all dosage ranges. Side effects which may be seen include drowsiness and orthostatic hypotension.

            Sertindole (Abbott Laboratories) is different from clozapine; it is selective for fewer receptors- primarily dopamine type 2 and serotonin type 2 receptors. It is effective against both positive and negative symptoms of schizophrenia without causing EPS, sedation, or anticholinergic effects. In a few patients, sertindole has caused nasal congestion, and some men have had decreased ejaculatory volume, but this was generally accompanied by normal sexual desire and function.

            Ziprasidone (Pfizer Labs Division) is a strong blocker of serotonin type 2a receptors and a moderate blocker of dopamine type 2 receptors. It also blocks serotonin type 2c and type 1d receptors but stimulates serotonin type 1a receptors. Because of its effects on other receptors, ziprasidone causes less low blood pressure and sedation than traditional antipsychotics.

 

WHEN CAN MEDICATIONS BE STOPPED?

Schizophrenia is usually a lifelong disease, like diabetes or high blood pressure. Most people with schizophrenia will probably need special medical care and medication for the rest of their lives. Antipychotic medications do not cure schizophrenia. They only control the symptoms of the disease.

            When people with schizophrenia stop taking their medication, they may have a relapse. That is, symptoms of an acute attack appear again. Most people who stop taking their medication will have a relapse within 1 year. It is very important that people with schizophrenia continue to take their medication to prevent new attacks.

            A few people continue to have psychotic attacks even when they take their medications. Their symptoms are probably less severe, however. Sometimes increasing the dose of the medication can stop a relapse.

           

HOW CAN RELAPSES BE PREVENTED?

The best way to prevent relapses is to continue to take the prescribed medication. People with schizophrenia may stop taking their medication for several reasons.

            Side effects are one of the most important reasons that people with schizophrenia stop taking their medication. It is hard for people to put up with unpleasant side effect for months or years. It is especially hard when the person feels well. It is very important to find the medication (and the dose) that controls symptoms without causing side effects.

            Convenience is also important. Some medications need to be taken two, three, or even four times a day. Others may be taken just once a day. People are more likely to remember to take a medication once a day than several times a day. Some people prefer to get injections every month of long-lasting medication (depot medication).

            Taking medications regularly is the best way to prevent repeated illness and hospitalization.

For more information contact

 

 

           The Alliance for the Mentally Ill

NAMI of Greater Chicago

1536 West Chicago Avenue

Chicago, IL 60622

(312) 563-0445

Fax 312-563-0467

namigc@aol.com

www.namigc.org